Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Best Practice Recommendations: User Acceptance Testing for Systems Designed to Collect Clinical Outcome Assessment Data Electronically.
Gordon S, Crager J, Howry C, Barsdorf AI, Cohen J, Crescioni M, Dahya B, Delong P, Knaus C, Reasner DS, Vallow S, Zarzar K, Eremenco S; Electronic Patient-Reported (ePRO) Consortium, PRO Consortium. Gordon S, et al. Among authors: reasner ds. Ther Innov Regul Sci. 2022 May;56(3):442-453. doi: 10.1007/s43441-021-00363-z. Epub 2022 Mar 1. Ther Innov Regul Sci. 2022. PMID: 35233726 Free PMC article.
Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: qualitative interview findings.
Newton L, Knight-West O, Eremenco S, Hudgens S, Crescioni M, Symonds T, Reasner DS, Byrom B, O'Donohoe P, Vallow S; Patient-Reported Outcome (PRO) Consortium; Electronic Clinical Outcome Assessment (eCOA) Consortium. Newton L, et al. Among authors: reasner ds. J Patient Rep Outcomes. 2022 Aug 4;6(1):86. doi: 10.1186/s41687-022-00492-5. J Patient Rep Outcomes. 2022. PMID: 35925498 Free PMC article.
Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD).
Taylor F, Higgins S, Carson RT, Eremenco S, Foley C, Lacy BE, Parkman HP, Reasner DS, Shields AL, Tack J, Talley NJ; Patient-Reported Outcome Consortiumʼs Functional Dyspepsia Working Group. Taylor F, et al. Among authors: reasner ds. Am J Gastroenterol. 2018 Jan;113(1):39-48. doi: 10.1038/ajg.2017.265. Epub 2017 Sep 19. Am J Gastroenterol. 2018. PMID: 28925989 Free PMC article.
Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Schoenfeld P, Lacy BE, Chey WD, Lembo AJ, Kurtz CB, Reasner DS, Bochenek W, Tripp K, Currie MG, Fox SM, Blakesley RE, OʼDea CR, Omniewski ND, Hall ML. Schoenfeld P, et al. Among authors: reasner ds. Am J Gastroenterol. 2018 Jan;113(1):105-114. doi: 10.1038/ajg.2017.230. Epub 2017 Aug 22. Am J Gastroenterol. 2018. PMID: 29091082 Free PMC article. Clinical Trial.
The Impact of Stool Consistency on Bowel Movement Satisfaction in Patients With IBS-C or CIC Treated With Linaclotide or Other Medications: Real-World Evidence From the CONTOR Study.
Taylor DCA, Abel JL, Doshi JA, Martin C, Goolsby Hunter A, Essoi B, Korrer S, Reasner DS, Carson RT, Chey WD. Taylor DCA, et al. Among authors: reasner ds. J Clin Gastroenterol. 2019 Nov/Dec;53(10):737-743. doi: 10.1097/MCG.0000000000001245. J Clin Gastroenterol. 2019. PMID: 31361710 Free PMC article.
Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
Yang Y, Fang J, Guo X, Dai N, Shen X, Yang Y, Sun J, Bhandari BR, Reasner DS, Cronin JA, Currie MG, Johnston JM, Zeng P, Montreewasuwat N, Chen GZ, Lim S. Yang Y, et al. Among authors: reasner ds. J Gastroenterol Hepatol. 2018 May;33(5):980-989. doi: 10.1111/jgh.14086. Epub 2018 Mar 12. J Gastroenterol Hepatol. 2018. PMID: 29319191 Clinical Trial.
29 results